MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$1,848,922
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from sale of securities...
Proceeds from sale of securities...
General and administrative costs
Others
Negative Cash Flow Breakdown
Net loss
Purchase of digital assets
Prepaid insurance
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
Net loss
-3,465,626
General and administrative costs
1,144,348
Common stock issued for services
44,711
Unrealized gain (loss) on digital assets
-182,887
Prepaid insurance
8,592
Other prepaid expenses
-23,814
Accounts payable and accrued expenses
95,661
Research and development contract liabilities
77
Net cash used in operating activities
-1,982,720
Purchase of digital assets
2,637,360
Net cash used in investing activities
-2,637,360
Proceeds from sale of securities in registered direct offerings, net of offering costs
2,245,040
Proceeds from sale of securities in registered private placement, net of offering costs
4,178,162
Exercise of common stock warrants
45,800
Net cash provided by financing activities
6,469,002
Net increase (decrease)
1,848,922
Cash and cash equivalents at beginning of period
1,038,952
Cash and cash equivalents at end of period
2,887,874
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sale of
securities in registered...
$4,178,162
Proceeds from sale of
securities in registered...
$2,245,040
Exercise of common stock
warrants
$45,800
Net cash provided by
financing activities
$6,469,002
Net increase
(decrease)
$1,848,922
Canceled cashflow
$4,620,080
General and
administrative costs
$1,144,348
Unrealized gain (loss) on
digital assets
-$182,887
Accounts payable and
accrued expenses
$95,661
Common stock issued for
services
$44,711
Other prepaid
expenses
-$23,814
Research and development
contract liabilities
$77
Net cash used in
investing activities
-$2,637,360
Net cash used in
operating activities
-$1,982,720
Canceled cashflow
$1,491,498
Purchase of digital
assets
$2,637,360
Net loss
-$3,465,626
Prepaid insurance
$8,592
Buy us a coffee
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXTW)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXTW)